Lindsay Mateo
Chief Business Officer
Lindsay is responsible for the Pierian growth strategy, overseeing new business, industry partnerships, and biopharma services.
Lindsay also spent 11 years at Genoptix, Inc., in San Diego, CA, holding commercial leadership roles and helping to drive a successful IPO in 2007 and eventual sale to Novartis in 2011.
Early in her career, Lindsay worked in oncology for Ortho Biotech, now part of Janssen Pharmaceutical Companies. She holds a bachelor's degree in Business and Corporate Communication from the College of Charleston and an MBA from Florida Atlantic University.